- Home
- QURE vs MEGI Comparison
QURE vs MEGI Comparison
Compare QURE & MEGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- MEGI
- Stock Information
- Founded
- QURE 1998
- MEGI 2021
- Country
- QURE Netherlands
- MEGI United States
- Employees
- QURE N/A
- MEGI N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- MEGI Investment Managers
- Sector
- QURE Health Care
- MEGI Finance
- Exchange
- QURE Nasdaq
- MEGI Nasdaq
- Market Cap
- QURE 750.6M
- MEGI 764.1M
- IPO Year
- QURE 2007
- MEGI N/A
- Fundamental
- Price
- QURE $16.98
- MEGI $12.19
- Analyst Decision
- QURE Strong Buy
- MEGI
- Analyst Count
- QURE 8
- MEGI 0
- Target Price
- QURE $32.43
- MEGI N/A
- AVG Volume (30 Days)
- QURE 4.7M
- MEGI 178.0K
- Earning Date
- QURE 11-05-2024
- MEGI 01-01-0001
- Dividend Yield
- QURE N/A
- MEGI 11.40%
- EPS Growth
- QURE N/A
- MEGI N/A
- EPS
- QURE N/A
- MEGI N/A
- Revenue
- QURE $28,587,000.00
- MEGI N/A
- Revenue This Year
- QURE $150.65
- MEGI N/A
- Revenue Next Year
- QURE N/A
- MEGI N/A
- P/E Ratio
- QURE N/A
- MEGI N/A
- Revenue Growth
- QURE N/A
- MEGI N/A
- 52 Week Low
- QURE $3.73
- MEGI $10.63
- 52 Week High
- QURE $17.71
- MEGI $14.89
- Technical
- Relative Strength Index (RSI)
- QURE 75.89
- MEGI 23.60
- Support Level
- QURE $14.68
- MEGI $13.13
- Resistance Level
- QURE $17.71
- MEGI $13.33
- Average True Range (ATR)
- QURE 1.58
- MEGI 0.27
- MACD
- QURE 0.64
- MEGI -0.11
- Stochastic Oscillator
- QURE 93.71
- MEGI 6.67
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund
MainStay CBRE Global Infrastructure Megatrends Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It invests predominantly in income-producing equity securities issued by infrastructure companies, including common stock, preferred stock, convertible securities, and rights or warrants to buy common stocks. The company intends to focus on three infrastructure megatrends: decarbonization, digital transformation, and asset modernization while making its investments.